4.27%XLF 16.00 10.11%QQQQ 32.65 6.34%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Shares of biotechnology companies traded mixed Tuesday as the broader market wobbled after consumer confidence data came in below expectations, UPS issued a profit warning and oil prices continued to rise, while the Federal Reserve began rate-setting meeting.
| GILD | 40.59 |  -1.29 |
| AMLN | 15.39 | -0.46 |
| AMGN | 51.69 | -3.29 |
| BIIB | 46.5 | -2.89 |
| DNA | 78.19 | -2.43 |
| CBST | 20.7000007629395 |  0.62 |
In industry news, R.W. Baird analyst Thomas Russo increased his price target for Gilead Sciences Inc. stock to $53 from $52, and raised his profit and revenue estimate, while trimming his estimates for Amylin Pharmaceuticals Inc.
Here's how several key biotechnology stocks performed Tuesday:
Gilead Sciences slipped 25 cents 54.52.
Amgen Inc. added 75 cents to $46.64.
Biogen Idec Inc. gained 6 cents to $56.59
Genentech Inc. gave up 76 cents to $73.42.
(This version corrects an earlier version that included Cubist Pharmaceuticals Inc. among the stocks for which Russo changed estimates.)
The trial of Skylar Deleon, former child actor on Mighty Morphin Power Rangers, ...
Tyler Perry made history on Saturday night by becoming the first African-America...
Getting the financial rescue through Congress may have been the easy part. Getti...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
